Laser Photonics Corporation (NASDAQ:LASE) ("Laser Photonics" or the "Company"), a global leader in laser systems for industrial and defense applications, today announced that its subsidiary, CMS Laser, has received a purchase order valued at approximately $1.05 million from a U.S.-based pharmaceutical company for a TD-70 high-speed pharmaceutical tablet drilling system. The order represents a first-time purchase by this customer and marks the Company's entry into a new pharmaceutical manufacturing account, further extending CMS Laser's precision laser drilling franchise within one of the most quality-intensive and highly regulated end markets it serves.